203 related articles for article (PubMed ID: 33534171)
1. Potential biomarkers for testicular germ cell tumour: Risk assessment, diagnostic, prognostic and monitoring of recurrence.
Lakpour N; Saliminejad K; Ghods R; Reza Sadeghi M; Pilatz A; Khosravi F; Madjd Z
Andrologia; 2021 May; 53(4):e13998. PubMed ID: 33534171
[TBL] [Abstract][Full Text] [Related]
2. miRNAs for testicular germ cell tumours: Contemporary indications for diagnosis, surveillance and follow-up.
Chavarriaga J; Hamilton RJ
Andrology; 2023 May; 11(4):628-633. PubMed ID: 36373757
[TBL] [Abstract][Full Text] [Related]
3. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
Lewin J; Soltan Ghoraie L; Bedard PL; Hamilton RJ; Chung P; Moore M; Jewett MAS; Anson-Cartwright L; Virtanen C; Winegarden N; Tsao J; Warde P; Sweet J; Haibe-Kains B; Hansen AR
BJU Int; 2018 Nov; 122(5):814-822. PubMed ID: 29726090
[TBL] [Abstract][Full Text] [Related]
6. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
[No Abstract] [Full Text] [Related]
7. Testicular germ cell tumor: a comprehensive review.
Batool A; Karimi N; Wu XN; Chen SR; Liu YX
Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Treatment of Testicular Cancer: A Clinician's Perspective.
Bernard B; Sweeney CJ
Surg Pathol Clin; 2015 Dec; 8(4):717-23. PubMed ID: 26612223
[TBL] [Abstract][Full Text] [Related]
9. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
11. Testicular germ cell tumors: biology and clinical update.
Nallu A; Mannuel HD; Hussain A
Curr Opin Oncol; 2013 May; 25(3):266-72. PubMed ID: 23549473
[TBL] [Abstract][Full Text] [Related]
12. Serum tumour markers in germ cell tumours: From diagnosis to cure.
Pedrazzoli P; Rosti G; Soresini E; Ciani S; Secondino S
Crit Rev Oncol Hematol; 2021 Mar; 159():103224. PubMed ID: 33493632
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in testicular germ cell tumor research.
van de Geijn GJ; Hersmus R; Looijenga LH
Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
[TBL] [Abstract][Full Text] [Related]
15. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract][Full Text] [Related]
16. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
[TBL] [Abstract][Full Text] [Related]
17. Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.
Evmorfopoulos K; Vlachostergios PJ; Sountoulides P; Tzortzis V
Curr Cancer Drug Targets; 2023; 23(11):858-867. PubMed ID: 36967458
[TBL] [Abstract][Full Text] [Related]
18. Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor.
Xavier R; de Carvalho RC; Fraietta R
Int Braz J Urol; 2021; 47(3):495-502. PubMed ID: 32459453
[TBL] [Abstract][Full Text] [Related]
19. [Testicular tumors--a current review].
Buse S; Lurati G; Schmid HP
Praxis (Bern 1994); 2003 Nov; 92(47):1989-97. PubMed ID: 14669500
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of urological malignancy: the testes.
Wilkins M; Horwich A
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]